Eric Lau

2.0k total citations
24 papers, 1.3k citations indexed

About

Eric Lau is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Eric Lau has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Eric Lau's work include Melanoma and MAPK Pathways (8 papers), DNA Repair Mechanisms (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Eric Lau is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), DNA Repair Mechanisms (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Eric Lau collaborates with scholars based in United States, Australia and United Kingdom. Eric Lau's co-authors include Ze’ev A. Ronai, Pablo Lopez‐Bergami, Wei Jiang, Changjun Zhu, G. Watson, Robert Schwarzenbacher, Ella Bossy‐Wetzel, Robert T. Abraham, David L. Rimm and Toshiya Tsuji and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature reviews. Cancer.

In The Last Decade

Eric Lau

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Lau United States 18 1.0k 292 289 253 146 24 1.3k
Karen M. Henkels United States 22 894 0.9× 194 0.7× 196 0.7× 325 1.3× 164 1.1× 44 1.3k
John J. Upson United States 10 1.2k 1.2× 378 1.3× 190 0.7× 335 1.3× 147 1.0× 11 1.5k
Dirk Mossmann Germany 9 1.2k 1.2× 248 0.8× 402 1.4× 248 1.0× 163 1.1× 9 1.7k
Xiao‐Dan Ji China 15 847 0.8× 220 0.8× 214 0.7× 241 1.0× 68 0.5× 19 1.1k
Larissa Kotelevets France 20 966 1.0× 211 0.7× 198 0.7× 317 1.3× 103 0.7× 29 1.5k
A. Pieter J. van den Heuvel United States 13 967 1.0× 160 0.5× 335 1.2× 363 1.4× 132 0.9× 14 1.4k
Shing Leng Chan Singapore 22 977 1.0× 152 0.5× 258 0.9× 375 1.5× 143 1.0× 33 1.4k
Yong-Nyun Kim South Korea 14 909 0.9× 285 1.0× 446 1.5× 353 1.4× 136 0.9× 31 1.5k
Onno B. Bleijerveld Netherlands 20 849 0.8× 290 1.0× 138 0.5× 204 0.8× 135 0.9× 44 1.3k
Craig D. Simpson Canada 16 901 0.9× 174 0.6× 382 1.3× 381 1.5× 168 1.2× 25 1.5k

Countries citing papers authored by Eric Lau

Since Specialization
Citations

This map shows the geographic impact of Eric Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lau more than expected).

Fields of papers citing papers by Eric Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lau. The network helps show where Eric Lau may publish in the future.

Co-authorship network of co-authors of Eric Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Lau. A scholar is included among the top collaborators of Eric Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Lau. Eric Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yang, Yi-Yu Lu, Eric Lau, et al.. (2017). Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis. Anticancer Research. 37(11). 6141–6151. 57 indexed citations
2.
Watson, G., Ze’ev A. Ronai, & Eric Lau. (2017). ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. Pharmacological Research. 119. 347–357. 103 indexed citations
3.
Claps, Giuseppina, Yann Chéli, Tongwu Zhang, et al.. (2016). A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. Cell Reports. 15(9). 1884–1892. 9 indexed citations
4.
Scortegagna, Marzia, Eric Lau, Tongwu Zhang, et al.. (2015). PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets. Cancer Research. 75(7). 1399–1412. 44 indexed citations
5.
Feng, Yongmei, Anthony B. Pinkerton, Laura Hulea, et al.. (2015). SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. Cancer Research. 75(24). 5211–5218. 26 indexed citations
6.
Jeon, Young Joo, Sihem Khelifa, Boris I. Ratnikov, et al.. (2015). Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies. Cancer Cell. 27(3). 354–369. 178 indexed citations
7.
Scortegagna, Marzia, Hyungsoo Kim, Jian‐Liang Li, et al.. (2014). Fine Tuning of the UPR by the Ubiquitin Ligases Siah1/2. PLoS Genetics. 10(5). e1004348–e1004348. 29 indexed citations
8.
Jeon, Young Joo, Sihem Khelifa, Yongmei Feng, et al.. (2014). Abstract 2440: RNF5 mediates ER stress-induced degradation of SLC1A5 in breast cancer. Cancer Research. 74(19_Supplement). 2440–2440. 4 indexed citations
9.
Varsano, Tal, Eric Lau, Yongmei Feng, et al.. (2013). Inhibition of Melanoma Growth by Small Molecules That Promote the Mitochondrial Localization of ATF2. Clinical Cancer Research. 19(10). 2710–2722. 17 indexed citations
10.
Lau, Eric, Harriet M. Kluger, Tal Varsano, et al.. (2012). PKCε Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria. Cell. 148(3). 543–555. 67 indexed citations
11.
Lau, Eric & Ze’ev A. Ronai. (2012). ATF2 – at the crossroad of nuclear and cytosolic functions. Journal of Cell Science. 125(Pt 12). 2815–24. 94 indexed citations
12.
Feng, Yongmei, Eric Lau, Marzia Scortegagna, et al.. (2012). Inhibition of melanoma development in the Nras(Q61K)::Ink4a−/− mouse model by the small molecule BI‐69A11. Pigment Cell & Melanoma Research. 26(1). 136–142. 16 indexed citations
13.
Lopez‐Bergami, Pablo, Eric Lau, & Ze’ev A. Ronai. (2010). Erratum: Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nature reviews. Cancer. 10(5). 379–379. 3 indexed citations
14.
Shah, Meera, Anindita Bhoumik, Vikas Goel, et al.. (2010). A Role for ATF2 in Regulating MITF and Melanoma Development. PLoS Genetics. 6(12). e1001258–e1001258. 63 indexed citations
15.
Lau, Eric, Gary G. Chiang, Robert T. Abraham, & Wei Jiang. (2009). Divergent S Phase Checkpoint Activation Arising from Prereplicative Complex Deficiency Controls Cell Survival. Molecular Biology of the Cell. 20(17). 3953–3964. 18 indexed citations
16.
Lopez‐Bergami, Pablo, Eric Lau, & Ze’ev A. Ronai. (2009). Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nature reviews. Cancer. 10(1). 65–76. 251 indexed citations
17.
Tsuji, Toshiya, Eric Lau, Gary G. Chiang, & Wei Jiang. (2008). The Role of Dbf4/Drf1-Dependent Kinase Cdc7 in DNA-Damage Checkpoint Control. Molecular Cell. 32(6). 862–869. 43 indexed citations
18.
Lau, Eric & Wei Jiang. (2006). Is There A Pre-RC Checkpoint That Cancer Cells Lack?. Cell Cycle. 5(15). 1602–1606. 8 indexed citations
19.
Zhu, Changjun, Eric Lau, Robert Schwarzenbacher, Ella Bossy‐Wetzel, & Wei Jiang. (2006). Spatiotemporal control of spindle midzone formation by PRC1 in human cells. Proceedings of the National Academy of Sciences. 103(16). 6196–6201. 121 indexed citations
20.
Lau, Eric, Changjun Zhu, Robert T. Abraham, & Wei Jiang. (2006). The functional role of Cdc6 in S–G2/M in mammalian cells. EMBO Reports. 7(4). 425–430. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026